Literature DB >> 1375927

Hemopoietic growth factors regulate the survival of human basophils in vitro.

M Yamaguchi1, K Hirai, Y Morita, T Takaishi, K Ohta, S Suzuki, K Motoyoshi, O Kawanami, K Ito.   

Abstract

Human basophils were purified from normal peripheral blood, using density gradient followed by negative panning selection. We tested the effects of hemopoietic growth factors on the survival of these basophils in vitro. In the absence of exogenous factors, basophils (purity greater than 90%) decreased in number rapidly. At day 7 only 11% of the cells remained alive in cultures; less than 1% of cells survived at day 14. Interleukin (IL)-3 maintained numbers of viable cells; cell viability was 67% at day 7 and 45% at day 14. Granulocyte-macrophage (GM)-colony-stimulating factor (CSF) exhibited slight effect on the survival; 33% of cells remained at day 7. Other growth factors including granulocyte (G)-CSF, macrophage (M)-CSF, and IL-4 had no significant effect on the survival of basophils at all. Morphological and functional characterization of cells maintained by IL-3 revealed that they belonged to the basophil lineage. These observations indicate that normal basophils possess functional receptors for IL-3 and GM-CSF and that both factors modulate immediate- and delayed-type hypersensitivity reactions by prolonging the life span of basophils.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375927     DOI: 10.1159/000236140

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

1.  Interleukin-3, but not granulocyte-macrophage colony-stimulating factor and interleukin-5, inhibits apoptosis of human basophils through phosphatidylinositol 3-kinase: requirement of NF-kappaB-dependent and -independent pathways.

Authors:  Xueyan Zheng; Aly Karsan; Vincent Duronio; Fanny Chu; David C Walker; Tony R Bai; R Robert Schellenberg
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

Review 2.  Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings.

Authors:  J E Frampton; Y E Yarker; K L Goa
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

3.  Acute side effects of homologous interleukin-3 in rhesus monkeys.

Authors:  F C van Gils; A H Mulder; C van den Bos; H Burger; R W van Leen; G Wagemaker
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

4.  IL-33 induces IL-9 production in human CD4+ T cells and basophils.

Authors:  Lars Blom; Britta C Poulsen; Bettina M Jensen; Anker Hansen; Lars K Poulsen
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

5.  Expression profiling of human basophils: modulation by cytokines and secretagogues.

Authors:  Donald MacGlashan
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

Review 6.  The Evolution of Human Basophil Biology from Neglect towards Understanding of Their Immune Functions.

Authors:  Markus Steiner; Sara Huber; Andrea Harrer; Martin Himly
Journal:  Biomed Res Int       Date:  2016-12-19       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.